Table 1.
Target | Mechanism of Li action | Result |
---|---|---|
G proteins | Inhibition | Adenyl cyclase inhibition Inhibition of PKA Decrease in cAMP concentration |
PI3K | Activation | Akt-1 activation GSK3β inhibition |
IMP IPP |
Inhibition | IP3 inhibition (leading to Ca2+ regulation) DAG inhibition (leading to PKC inhibition) GSK3β inhibition |
Akt/PKB | Activation | GSK3β inhibition Inhibition of pro-apoptotic factors Decrease in expression of p53 and Bax proteins |
GSK3β | Inhibition | Glycogen synthase activation Nuclear factor-κB activation Inhibition of pro-apoptotic factors |
CREB | Inhibition | Increased expression of BDNF Increased expression of dynorphins |
Akt/PKB, RAC-alpha serine/threonine-protein kinase; BDNF, brain-derived neurotrophic factor; CREB, cAMP response element-binding protein; DAG, diacylglycerol; GSK3β, glycogen synthase kinase 3 beta; IMP, inosine monophosphate; IP3, inositol trisphosphate; IPP, inositol polyphosphate 1-phosphatase; PI3K, phosphatidylinositol-4,5-bisphosphate 3-kinase; PKA, protein kinase A; PKC, protein kinase C